Protosappanin B

Research use only, not for human use.

Protosappanin B significantly increases cell viability, inhibits cell apoptosis and up-regulates the expression of growth-associated protein 43.

Protosappanin B significantly increases cell viability, inhibits cell apoptosis and up-regulates the expression of growth-associated protein 43. Protosappanin B induces the degradation of p53 protein, via activation of a MDM2-dependent ubiquitination process.

Protosappanin B (12.5, 25, 50, 100, 200 μg/mL, 48 hours) dose-dependently inhibits tumor cells, with IC50s of 21.32 μg/mL, 26.73 μg/mL, and 76.53 μg/mL for SW-480, HCT-116, and BTT cells, respectively. Cell Viability Assay Cell Line:CT-116, SW-480, and BTT Cells Concentration:12.5, 25, 50, 100, 200 μg/mL Incubation Time:48 hours Result:Dose-dependently inhibited tumor cells after 48 hours of treatment.

——

(-)-Protosappanin B

Others

Other Targets

Others

Others-Field

——

102036-29-3

304.29

C16H16O6

>98% (HPLC)

In Vitro:?DMSO : 50 mg/mL (164.32 mM)

C1C2=CC(=C(C=C2C3=C(C=C(C=C3)O)OCC1(CO)O)O)O

——

(-20℃)

With Ice Pack

≥ 2 years